Preámbulo 1
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products ( 1 ) , and in particular Article 15(1) and Article 15(2), fourth subparagraph, thereof,
Whereas:
HAS ADOPTED THIS REGULATION:
recital 1recital 1
(1) Regulation (EC) No 1272/2008 of the European Parliament and of the Council ( 2 ) provides for a harmonised classification of substances as carcinogenic, mutagenic or toxic for reproduction (CMR) based on a scientific assessment by the Risk Assessment Committee of the European Chemicals Agency. The substances are classified as CMR substances of category 1A, CMR substances of category 1B or CMR substances of category 2 depending on the level of evidence of their CMR properties.
recital 2recital 2
(2) Article 15 of Regulation (EC) No 1223/2009 provides that substances which have been classified as CMR substances of category 1A, category 1B or category 2 under Part 3 of Annex VI to Regulation (EC) No 1272/2008 (CMR substances) are to be prohibited from use in cosmetic products. A CMR substance may however be used in cosmetic products where the conditions laid down in Article 15(1), second sentence, of Regulation (EC) No 1223/2009 or in Article 15(2), second subparagraph of that Regulation are fulfilled.
recital 3recital 3
(3) In order to uniformly implement the prohibition of CMR substances within the internal market, to ensure legal certainty, in particular for economic operators and national competent authorities, and to ensure a high level of protection of human health, all CMR substances should be included in the list of prohibited substances in Annex II to Regulation (EC) No 1223/2009 and, where relevant, deleted from the lists of restricted or allowed substances in Annexes III to VI to that Regulation. Where the conditions laid down in Article 15(1), second sentence, of Regulation (EC) No 1223/2009 or in Article 15(2), second subparagraph of that Regulation are fulfilled, the lists of restricted or allowed substances in Annexes III to VI to that Regulation should be amended accordingly.
recital 4recital 4
(4) This Regulation covers substances classified as CMR substances by Commission Delegated Regulation (EU) 2022/692 ( 3 ) (‘the relevant substances’). Delegated Regulation (EU) 2022/692 will apply from 1 December 2023.
recital 5recital 5
(5) No request for use in cosmetic products by way of exception has been submitted for the relevant substances.
recital 6recital 6
(6) The relevant substances are currently neither restricted in Annex III to Regulation (EC) No 1223/2009, nor allowed in Annexes IV, V or VI to that Regulation.
recital 7recital 7
(7) The substance 2-ethylhexanoic acid (CAS No 149-57-5) is currently listed in entry 1024 of Annex II to Regulation (EC) No 1223/2009. However, the salts of that substance, which have been classified as CMR substances [of category 1B] by Delegated Regulation (EU) 2022/692, are not included in that entry. None of the other relevant substances are currently listed in Annex II to Regulation (EC) No 1223/2009. Therefore, those substances should be added to the list of substances prohibited in cosmetic products in Annex II to Regulation (EC) No 1223/2009 and the salts of the substance 2-ethylhexanoic acid should be added in entry 1024 of that Annex.
recital 8recital 8
(8) Regulation (EC) No 1223/2009 should therefore be amended accordingly.
recital 9recital 9
(9) The amendments to Regulation (EC) No 1223/2009 are based on the classifications of the relevant substances as CMR substances and should therefore apply from the same date as those classifications.
recital 10recital 10
(10) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Cosmetic Products,
Artículo 1
Annexes II to Regulation (EC) No 1223/2009 is amended in accordance with the Annex to this Regulation.
Artículo 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
It shall apply from 1 December 2023.
Anexo 1ANNEX
Annex II to Regulation (EC) No 1223/2009 is amended as follows:
(1) entry 1024 is replaced by the following: Reference number Substance identification Chemical name/INN CAS number EC number a b c d ‘1024 2-ethylhexanoic acid and its salts with the exception of those specified elsewhere in Annex VI to Regulation (EC) No 1272/2008 149-57-5/- 205-743-6/-’
(2) the following entries are added: Reference number Substance identification Chemical name/INN CAS number EC number a b c d ‘1695 Ammonium bromide 12124-97-9 235-183-8 1696 Dibutyltin bis(2-ethylhexanoate) 2781-10-4 220-481-2 1697 Dibutyltin di(acetate) 1067-33-0 213-928-8 1698 Tellurium dioxide 7446-07-3 231-193-1 1699 Barium diboron tetraoxide 13701-59-2 237-222-4 1700 2,2-dimethylpropan-1-ol,tribromo derivative; 3-bromo-2,2-bis(bromomethyl)propan-1-ol 36483-57-5/1522-92-5 253-057-0/- 1701 2,4,6-tri-tert-butylphenol 732-26-3 211-989-5 1702 4,4’-sulphonyldiphenol; bisphenol S 80-09-1 201-250-5 1703 Benzophenone 119-61-9 204-337-6 1704 Quinoclamine (ISO); 2-amino-3-chloro-1,4-naphthoquinone 2797-51-5 220-529-2 1705 Perfluoroheptanoic acid; tridecafluoroheptanoic acid 375-85-9 206-798-9 1706 methyl N -(isopropoxycarbonyl)-L-valyl-(3RS)-3-(4-chlorophenyl)-β-alaninate; valifenalate 283159-90-0 608-192-3 1707 6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid, sodium and tris(2-hydroxyethyl)ammonium salts - 701-271-4 1708 6-[(C10-C13)-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid 2156592-54-8 701-118-1 1709 6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid - 701-162-1 1710 Theophylline; 1,3-dimethyl-3,7-dihydro-1 H -purine-2,6-dione 58-55-9 200-385-7 1711 1,3,5-triazine-2,4,6-triamine; melamine 108-78-1 203-615-4 1712 Fluopicolide (ISO); 2,6-dichloro-N-[3-chloro-5-(trifluoromethyl)-2-pyridylmethyl]benzamide 607-285-6 239110-15-7 1713 N -(2-nitrophenyl)phosphoric triamide 874819-71-3 477-690-9 1714 N -(5-chloro-2-isopropylbenzyl)- N -cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1 H -pyrazole-4-carboxamide; isoflucypram 1255734-28-1 811-438-4 1715 Reaction mass of 3-(difluoromethyl)-1-methyl-N-[(1 RS ,4 SR ,9 RS )-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide and 3-(difluoromethyl)-1-methyl-N-[(1 RS ,4 SR ,9 SR )-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide [≥ 78 % syn isomers ≤ 15 % anti isomers relative content]; isopyrazam 881685-58-1 632-619-2 1716 Margosa, ext. [from the kernels of Azadirachta indica extracted with water and further processed with organic solvents] 84696-25-3 283-644-7 1717 Cumene 98-82-8 202-704-5 1718 2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3-propanediyl diacrylate; 2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate; 15625-89-5 239-701-3 1719 Pentapotassium 2,2’,2’’,2’’’,2’’’’-(ethane-1,2-diylnitrilo)pentaacetate 7216-95-7 404-290-3 1720 N-carboxymethyliminobis(ethylenenitrilo)tetra(acetic acid); Pentetic Acid (INCI) 67-43-6 200-652-8 1721 Pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate; Pentasodium Pentetate (INCI) 140-01-2 205-391-3 1722 Acetamiprid (ISO); (1 E )- N -[(6-chloropyridin-3-yl)methyl]- N’ -cyano- N -methylethanimidamide; (E)- N 1-[(6-chloro-3-pyridyl)methyl]- N 2-cyano- N 1-methylacetamidine 135410-20-7/ 160430-64-8 603-921-1/ 682-791-8 1723 Pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidene 40487-42-1 254-938-2 1724 Bentazone (ISO); 3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide 25057-89-0 246-585-8’